Frankfurt, Germany, 16 October 2025: When Luc Donckerwolke, Chief Creative Officer of Genesis, speaks about Magma, his passion is clear.…
October 14, 2025 16:35 ET | Source: EyePoint Pharmaceuticals, Inc. WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals,…
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology…
October 10, 2025 16:41 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals,…
October 10, 2025 17:16 ET | Source: Bluejay Diagnostics, Inc. ACTON, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics,…
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, ITALY,…
October 03, 2025 16:05 ET | Source: Diginex Limited LONDON, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (NASDAQ: DGNX)…
October 03, 2025 16:01 ET | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio…
October 02, 2025 21:00 ET | Source: NextGen Digital Platforms Inc. Vancouver, B.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- NextGen…
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Algae-C Inc. (“Algae-C”) today issues a correction to its earlier release announcing its…